Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Intraarticular Steroid Injection for Enhancing Pain Relief in Adhesive Capsulitis
NCT ID: NCT07235982
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2025-10-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Effect of Shoulder Anterior Capsular Block Versus Suprascapular Nerve Block in Patients With Frozen Shoulder
NCT06725823
Comparison of the Effects Suprascapular Nerve Block and Intra-articular Shoulder Injection
NCT05909462
Effects of Intra-articular Versus Subacromial Steroid Injections on Clinical Outcomes in Adhesive Capsulitis
NCT00742846
Best Treatment Modality of Frozen Shoulder
NCT04897308
The Effect of Mesotherapy and Intra-articular Steroid Injection in Shoulder Pain
NCT06610032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To measure analgesic parameters including: assessment of pain score by using Visual Analogue Score during 8 weeks follow up in comparison to baseline and total amount of rescue analgesic (ibuprofen) consumption.
* To assess the Shoulder pain and Disability Index
* To record complications of the block (local anesthetic toxicity, infection, bleeding, nerve injury)
* Over all patient's satisfaction: The patients will be asked to rate the overall degree of satisfaction of the analgesia by using a 5-points likert-like verbal scale (1 = very dissatisfied analgesia, 2 = dissatisfied analgesia, and 3 = neutral, 4=satisfied analgesia, and 5=very satisfied analgesia).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Shoulder anterior capsular block (SHAC)
patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint
Group Group Shoulder anterior capsular block (SHAC)
patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint followed by home exercise program.
Group intraarticular steroid injection (IASI)
patients will receive intraarticular steroid injection of the affected shoulder joint
Group intraarticular steroid injection (IASI)
patients will receive intraarticular steroid injection of the affected shoulder joint followed by home exercise program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Group Shoulder anterior capsular block (SHAC)
patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint followed by home exercise program.
Group intraarticular steroid injection (IASI)
patients will receive intraarticular steroid injection of the affected shoulder joint followed by home exercise program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 41-65 years old
* Sex: both sex (males or females).
* Physical status: American Society of Anesthesiologist (ASA) І, II.
* Patients attend orthopedic or pain clinic with complaint of shoulder pain and stiffness. These patients received conservative management of pain with no relief of symptoms for at least 2 weeks.
Exclusion Criteria
* Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
* Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).
* Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.
* History of neuropathy in the involved limb or previous revision surgery.
41 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Abdelhameed Elsadek Salem
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dina Salem, MD
Role: PRINCIPAL_INVESTIGATOR
FACULTY OF MEDICINE, ZAGAZIG UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculity of Medicine, Zagazig University
Zagazig, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1593
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.